Papilla on a thyroid FNA. What is your first impression?🧐 A) Follicular neoplasm B) Papillary thyroid carcinoma C) Something else #CytoPath #Thyroid #Pathology #PathTwitter

Artificial Intelligence–Based Classification of Renal Oncocytic Neoplasms from Collins et al. “The proposed artificial intelligence approach contributes toward a comprehensive solution for addressing commonly encountered renal oncocytic neoplasms…” bit.ly/4hUMUQd

Controversial but crucial: The new WHO Blue Books heavily rely on molecular diagnostics, tools inaccessible to up to 80% of the world’s population. Instead of addressing global inequality, they risk deepening it. Radical, inclusive change is urgently needed.

I applaud both of you for your pro bono work. But unless we empower local pathologists, it won’t go far - real change hinges on building local capacity. On dual classifications: I agree, they confuse more than help. So here’s a radical solution: The primary WHO classification

This is directed at the authors, editors, and administrators of the WHO Blue Books: 1️⃣ If a chapter relies on genetic testing unavailable to >80% of the world, it serves no one but those who already know the disease. Rewrite it. 2️⃣ If you plan to change nomenclature, ask: Does

Peer review fuels a billion-dollar publishing industry. Reviewers go unpaid, authors pay to publish, and the public face paywalls. If we’re serious about reforming science, this broken system is another good place to start.

Beautiful surgical anatomy illustration from 1846 #histmed #histsurg #anatomy #pastmedicalhistory

I agree —but I also expect more from the World Health Organization. To me, this isn’t just an oversight. It feels anti-diversity, anti-equity, and anti-inclusion. I am particularly shocked by the complete lack of representation from the Global South in the Female Genital Tumours

Cayó un árbol en puente peatonal de la glorieta Mariscal Sucre, entre av división del norte y av colonia del Valle En la Del Valle Alcaldía de Benito Juárez 25/05/25

Endometrial carcinoma-Molecular classification NSMP (non-specific molecular profile) EC group can be separated in two -Low grade ER positive -High grade ER negative Low-grade and ER-positive NSMP ECs are a homogeneous low-risk group associated with an exceptionally favorable

Don't be fooled! Dense stromal fibrosis and fibrocystic changes can present as architectural distortion, mimicking malignancy on imaging. thepathprincess.substack.com/p/fibrocystic-… Correlation and a keen eye are essential. #pathology #pathologist #breastpath #breastpathology

Large serous cystadenoma (the patient became symptomatic, necessitating surgical resection). These large #SCAs (and those with accelerated growth) often acquire not only VHL alterations, but mutations in TP53, hTERT, and IDH1/2. #Pathology #GIPathology #Pancreas #PancreaticCysts

The OLGIMA system for gastric cancer risk assessment. A useful method based on the histological Sydney consensus - Delgado Guillena - Histopathology - Wiley Online Library #gipath onlinelibrary.wiley.com/doi/10.1111/hi…

Kidney Pathology Certificate Program (KPCP) live session highlight: Dr. Paul Miller teaching about MCD & FSGS. Learn more and pre-register for the program here: glomcon.org/for-mds/kidney…

Extrathyroidal Extension If there are intraoperative findings, gross examination, or radiologic findings supporting ETE into muscle (in addition to microscopic evidence), stage as pT3b. If only microscopic ETE is present without such supporting evidence, stage as pT1–pT3a based

NIFTP or not NIFTP? Round, well-demarcated lesion with nuclear changes resembling NIFTP (pic 1). Penultimate and tip sections show irregularities in the external surface (pic 2-3). Using an orange as analogy (pic 4), such irregularities are common at the tips. If these

Updates on the pathology of adrenal tumors from Rumeal D. Whaley, MD onlinelibrary.wiley.com/doi/epdf/10.11…

"Think of the rivers of blood spilled by all those generals and emperors so that, in glory and triumph, they could become the momentary masters of a fraction of a dot." – Carl Sagan

Today I learned if someone with prostrate cancer develops liver mets, you need to re-biopsy the liver mets to rule out neuroendocrine or squamous cell transformation, which would change management.

We hope you find useful our new publication describing the changes in the GI6 volume of the WHO Blue Books. IARC #Pathology #GIPathology #PediPath Open access: doi.org/10.1111/his.70… UMiami Pathology tumourclassification.iarc.who.int/home